Enterprise Equity

Enterprise Equity is a long-tenured Irish venture capital firm based in Dublin that has spent decades partnering with locally rooted founders building digital health and medical device businesses. The group operates as a generalist early-stage investor, but healthcare consistently shows up in its activity given the strength of Ireland’s medtech cluster and its proximity to academic research output. Rather than chase thematic trends, the team tends to back companies addressing established clinical or operational problems with credible commercial paths, with no formal AI-first mandate guiding allocation. Limited public information is available about the current investment team and named partners.

Enterprise Equity concentrates on Seed and Series A rounds, deploying checks in the $250k to $1M range, which positions the fund as a meaningful but not necessarily lead investor in many syndicates. Geographic focus is firmly Ireland, with companies based in Dublin and other domestic hubs forming the core of the pipeline. The firm has historically participated alongside Enterprise Ireland and other domestic co-investors, helping startups bridge the gap between non-dilutive grant capital and institutional growth rounds.

Founders engaging with Enterprise Equity should expect a relationship-driven, hands-on approach informed by the firm’s long memory of the Irish startup ecosystem. The team is likely to value fundamentals, capital efficiency, and clear progression milestones rather than rapid follow-on stacking. Given the fund’s positioning, founders raising larger checks or seeking heavy AI specialization may find it a better fit as a co-investor than as a sole lead. For Irish digital health and medtech entrepreneurs at the early scaling chasm, however, Enterprise Equity offers patient local capital with clear domain familiarity.